[1] |
史玉玲, 徐晓光, 毕新岭, 等. 白介素22及其相关因子在银屑病患者血清及外周血单一核细胞中的表达[J]. 中华皮肤科杂志, 2011, 44(4): 238⁃240. DOI: 10.3760/cma.j.issn.0412⁃4030.2011. 04.005.
|
|
Shi YL, Xu XG, Bi XL, et al. Expressions of interleukin (IL)⁃22 and related cytokines in the sera and peripheral blood mononuclear cells of patients with psoriasis[J]. Chin J Dermatol, 2011, 44(4): 238⁃240. DOI: 10.3760/cma.j.issn.0412⁃4030.2011.04.005.
|
[2] |
Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell, 2009, 136(2): 215⁃233. DOI: 10.1016/j.cell.2009.01. 002.
|
[3] |
Labbaye C, Testa U. The emerging role of MIR⁃146A in the control of hematopoiesis, immune function and cancer[J]. J Hematol Oncol, 2012, 5: 13. DOI: 10.1186/1756⁃8722⁃5⁃13.
|
[4] |
Li J, Wan Y, Guo Q, et al. Altered microRNA profile with miR⁃146a upregulation in CD4+ T cells from patients with rheumatoid arthritis[J]. Arthritis Res Ther, 2010, 12(3): R81. DOI: 10.1186/ar3006.
|
[5] |
Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs: novel regulators in skin inflammation[J]. Clin Exp Dermatol, 2008, 33(3): 312⁃315. DOI: 10.1111/j.1365⁃2230.2008.02804.x.
|
[6] |
中华医学会皮肤性病学分会银屑病学组. 中国银屑病治疗指南(2008版)[J]. 中华皮肤科杂志, 2009, 42(3): 213⁃214. DOI: 10.3760/cma.j.issn.0412⁃4030.2009.03.030.
|
|
Psoriasis Group of Chinese Society of Dermatology. Guidelines for the treatment of psoriasis in China(2008)[J]. Chin J Dermatol, 2009, 42(3): 213⁃214. DOI: 10.3760/cma.j.issn.0412⁃4030.2009. 03. 030.
|
[7] |
Livak KJ, Schmittgen TD. Analysis of relative gene data using real⁃time quantitative PCR and the 2(⁃Delta Delta C(T)) Method[J]. Methods, 2001, 25(4): 402⁃408. DOI: 10.1006/meth.2001.1262.
|
[8] |
李晓, 古桂雄, 李巍. 微小核糖核苷酸146a在相关皮肤病中的研究进展[J]. 国际皮肤性病学杂志, 2015, 41(2): 109⁃111. DOI: 10.3760/cma.j.issn.1673⁃4173.2015.02.014.
|
|
Li X, Gu GX, Li W, et al. MicroRNA⁃146a in related dermatoses. Int J Dermatol Venereol, 2015, 4(2): 109⁃111. DOI: 10.3760/cma.j.issn.1673⁃4173.2015.02.014.
|
[9] |
Majoros WH, Ohler U. Spatial preferences of microRNA targets in 3′ untranslated regions[J]. BMC Genomics, 2007, 8: 152. DOI:10. 1186/1471⁃2164⁃8⁃152.
|
[10] |
Zibert JR, Løvendorf MB, Litman T, et al. MicroRNAs and potential target interactions in psoriasis[J]. J Dermatol Sci, 2010, 58(3): 177⁃185. DOI: 10.1016/j.jdermsci.2010.03.004.
|
[11] |
Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis[J]. PLoS ONE, 2007, 2(7): e610. DOI: 10.1371/journal.pone.0000610.
|
[12] |
Koga Y, Jinnin M, Ichihara A, et al. Analysis of pattern of serum microRNA levels in patients with psoriasis[J]. J Dermatol Sci, 2014, 74(2): 170⁃171. DOI: 10.1016/j.jdermsci.2014.01.005.
|
[13] |
Chatzikyriakidou A, Voulgari PV, Georgiou I, et al. The role of microRNA⁃146a (miR⁃146a) and its target IL⁃1R⁃associated kinase (IRAK1) in psoriatic arthritis susceptibility[J]. Scand J Immunol, 2010, 71(5): 382⁃385. DOI: 10.1111/j.1365⁃3083.2010. 02381.x.
|
[14] |
Park H, Huang X, Lu C, et al. MicroRNA⁃146a and microRNA⁃146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins[J]. J Biol Chem, 2015, 290(5): 2831⁃2841. DOI: 10.1074/jbc.M114.591420.
|
[15] |
Pedersen I, David M. MicroRNAs in the immune response[J]. Cytokine, 2008, 43(3): 391⁃394. DOI: 10.1016/j.cyto.2008.07.016.
|
[16] |
Cobb BS, Hertweck A, Smith J, et al. A role for Dicer in immune regulation[J]. J Exp Med, 2006, 203(11): 2519⁃2527. DOI:10.1084/jem.20061692.
|
[17] |
Guo M, Mao X, Ji Q, et al. miR⁃146a in PBMCs modulates Th1 function in patients with acute coronary syndrome[J]. Immunol Cell Biol, 2010, 88(5): 555⁃564. DOI: 10.1038/icb.2010.16.
|
[18] |
Riedmann LT, Schwentner R. miRNA, siRNA, piRNA and argonautes: news in small matters[J]. RNA Biol, 2010, 7(2): 133⁃139.
|